One of the most frequently mutated genes in CH and myeloid malignancies is Ten-Eleven Translocation-2 (TET2), an epigenetic enzyme that regulates DNA demethylation and gene activation associated with myeloid cell differentiation. This evidence concerns the gene TET2 and myeloid neoplasm.